Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Type

Type

Guidance programme 3 selected

Guidance programme

Showing 1 to 25 of 82

TitleReference numberPublishedLast updated
Leniolisib for treating activated phosphoinositide 3-kinase delta syndrome in people 12 years and overHST33
Burosumab for treating X-linked hypophosphataemia in children and young peopleHST8
Olipudase alfa for treating acid sphingomyelinase deficiency (Niemann–Pick disease) type AB and type BHST32
Home-testing devices for diagnosing obstructive sleep apnoea hypopnoea syndromeDG62
Heart failure algorithms for remote monitoring in people with cardiac implantable electronic devicesDG61
Digital technologies for assessing attention deficit hyperactivity disorder (ADHD)DG60
CYP2C19 genotype testing to guide clopidogrel use after ischaemic stroke or transient ischaemic attackDG59
Setmelanotide for treating obesity and hyperphagia in Bardet-Biedl syndromeHST31
Tumour profiling tests to guide adjuvant chemotherapy decisions in early breast cancerDG58
Artificial intelligence (AI)-derived software to help clinical decision making in strokeDG57
Devices for remote monitoring of Parkinson's diseaseDG51
Sebelipase alfa for treating Wolman diseaseHST30
Velmanase alfa for treating alpha-mannosidosisHST29
Birch bark extract for treating epidermolysis bullosaHST28
Quantitative faecal immunochemical testing to guide colorectal cancer pathway referral in primary careDG56
Afamelanotide for treating erythropoietic protoporphyriaHST27
AI-derived computer-aided detection (CAD) software for detecting and measuring lung nodules in CT scan imagesDG55
FibroScan for assessing liver fibrosis and cirrhosis outside secondary and specialist careDG48
Transperineal biopsy for diagnosing prostate cancerDG54
MRI fusion biopsy systems for diagnosing prostate cancerDG53
Automated ankle brachial pressure index measurement devices to detect peripheral arterial disease in people with leg ulcersDG52
Lumasiran for treating primary hyperoxaluria type 1HST25
Onasemnogene abeparvovec for treating spinal muscular atrophyHST15
Eladocagene exuparvovec for treating aromatic L-amino acid decarboxylase deficiencyHST26
Onasemnogene abeparvovec for treating presymptomatic spinal muscular atrophyHST24

Results per page

  1. 10
  2. 25
  3. 50
  4. All